Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the monthly archives: December, 2018

We are pleased to present below all posts archived in 'December, 2018'. If you still can't find what you are looking for, try using the search box.

AMSBIO introduces ALiCE® - a new high yield cell-free protein expression system.

Cell-free protein expression (CFPE) is today used by protein chemists to quickly produce small amounts of proteins when screening DNA libraries. However current technologies are limited and there is a need for higher protein expression yields.

Read the rest of entry »

Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies

Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) with a focus on advanced therapy medicinal products (ATMPs) has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency.

Read the rest of entry »

Birmingham to lead ground-breaking research into patient experience of cell therapies

Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded £1.1 million by UK Research & Innovation (UKRI)’s Innovate UK, to investigate patients’ experience of cell and gene therapies.

Read the rest of entry »

Chronos Therapeutics Announces Positive Pre-clinical Proof of Concept in MS Fatigue Model

Chronos Therapeutics Announces Positive Pre-clinical Proof of Concept in MS Fatigue Model. Patents for the Fatigue programme awarded in USA and Europe. 

Read the rest of entry »

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, will showcase its expertise in Phase I Clinical Trials in Australia with a series of West Coast US seminars in January 2019. 

Read the rest of entry »

The UK’s first dedicated Vaccines Manufacturing Innovation Centre to be located at The Oxford Science Park

The UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) will be located at The Oxford Science Park (TOSP), one of the UK's leading parks for science and technology companies, it was announced today

Read the rest of entry »

Changes in Leadership at BioCity Group

BioCity Group has today announced that its founding CEO, Dr Glenn Crocker, MBE, will be stepping down at the end of the year and taking up the role of Chairman.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.